Laura Magazzini : Citation Profile


Are you Laura Magazzini?

Scuola Superiore Sant'Anna

9

H index

8

i10 index

413

Citations

RESEARCH PRODUCTION:

16

Articles

35

Papers

RESEARCH ACTIVITY:

   20 years (2001 - 2021). See details.
   Cites by year: 20
   Journals where Laura Magazzini has often published
   Relations with other researchers
   Recent citing documents: 34.    Total self citations: 16 (3.73 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pma1141
   Updated: 2023-01-28    RAS profile: 2022-08-13    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Stampini, Marco (4)

Bruno, Randolph (4)

Calzolari, Giorgio (3)

Pertile, Paolo (2)

Gamba, Simona (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Laura Magazzini.

Is cited by:

Pammolli, Fabio (14)

Harhoff, Dietmar (12)

van Reenen, John (10)

Chetty, Raj (10)

Jaravel, Xavier (8)

Geuna, Aldo (8)

SALERNO, Nicola (8)

Verspagen, Bart (7)

Riccaboni, Massimo (7)

nagaoka, sadao (6)

de Rassenfosse, Gaétan (5)

Cites to:

Jaffe, Adam (50)

Trajtenberg, Manuel (46)

Pammolli, Fabio (35)

Hall, Bronwyn (32)

Riccaboni, Massimo (25)

Harhoff, Dietmar (16)

Nelson, Richard (15)

Danzon, Patricia (12)

Orsenigo, Luigi (12)

Cockburn, Iain (11)

Griliches, Zvi (10)

Main data


Where Laura Magazzini has published?


Journals with more than one article published# docs
The European Journal of Health Economics2
Stata Journal2
Econometric Reviews2

Working Papers Series with more than one paper published# docs
Working Papers / University of Verona, Department of Economics12
Working Papers CERM / Competitivit, Regole, Mercati (CERM)8
MPRA Paper / University Library of Munich, Germany5
Working Papers / IMT School for Advanced Studies Lucca2

Recent works citing Laura Magazzini (2022 and 2021)


YearTitle of citing document
2022Valuing Pharmaceutical Drug Innovations: An Event Study Approach. (2022). Khmelnitskaya, Ekaterina ; Farmer, Leland E ; Ciliberto, Federico ; Aryal, Gaurab. In: Papers. RePEc:arx:papers:2212.07384.

Full description at Econpapers || Download paper

2021Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly. (2021). Gamba, Simona ; Florio, Massimo. In: Annals of Public and Cooperative Economics. RePEc:bla:annpce:v:92:y:2021:i:3:p:387-409.

Full description at Econpapers || Download paper

2021DEPARTURE AND PROMOTION OF U.S. PATENT EXAMINERS: DO PATENT CHARACTERISTICS MATTER?. (2021). Lluis, Stephanie ; Langinier, Corinne. In: Contemporary Economic Policy. RePEc:bla:coecpo:v:39:y:2021:i:2:p:416-434.

Full description at Econpapers || Download paper

2021The strategic allocation of inventors to R&D collaborations. (2021). Wehrheim, David ; Palomeras, Neus. In: Strategic Management Journal. RePEc:bla:stratm:v:42:y:2021:i:1:p:144-169.

Full description at Econpapers || Download paper

2021Does age matter? The impact of SMEs age on the relationship between knowledge sourcing strategy and internationalization. (2021). Mazzoleni, Alberto ; Santoro, Gabriele ; Solima, Ludovico ; Quaglia, Roberto. In: Journal of Business Research. RePEc:eee:jbrese:v:128:y:2021:i:c:p:779-787.

Full description at Econpapers || Download paper

2022Division of labor in R&D? Firm size and specialization in corporate research. (2022). Hottenrott, Hanna ; Mukherjee, Anwesha ; Becker, Annette. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:194:y:2022:i:c:p:1-23.

Full description at Econpapers || Download paper

2021Energy based estimation of the shadow economy: The role of governance quality. (2021). Dergiades, Theologos ; Missiou, Olympia ; Psychoyios, Dimitrios. In: The Quarterly Review of Economics and Finance. RePEc:eee:quaeco:v:80:y:2021:i:c:p:797-808.

Full description at Econpapers || Download paper

2021Regional innovation effects of applied research institutions. (2021). Koomen, Miriam ; Backes-Gellner, Uschi ; Harhoff, Dietmar ; Pfister, Curdin. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:4:s0048733321000019.

Full description at Econpapers || Download paper

2021Patent Quality: Towards a Systematic Framework for Analysis and Measurement. (2021). Jaffe, Adam ; Higham, Kyle ; de Rassenfosse, Gaétan. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:4:s0048733321000196.

Full description at Econpapers || Download paper

2022Breakthrough innovations and where to find them. (2022). Nuvolari, Alessandro ; Martinelli, Arianna ; Capponi, Giovanna. In: Research Policy. RePEc:eee:respol:v:51:y:2022:i:1:s0048733321001724.

Full description at Econpapers || Download paper

2021A revisit of capital structure puzzle: Global evidence and analysis. (2021). Hossain, Mohammed Sawkat. In: International Review of Economics & Finance. RePEc:eee:reveco:v:75:y:2021:i:c:p:657-678.

Full description at Econpapers || Download paper

2021Assessing the value of Chinas patented inventions. (2021). Mao, Hao ; Shen, Huijun ; Huang, Can. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:170:y:2021:i:c:s0040162521003000.

Full description at Econpapers || Download paper

2022Motives to Publish, to Patent and to Standardize: An Explorative Study Based on Individual Engineers’ Assessments. (2022). Lazina, Luisa K ; Filipovi, Ellen ; Blind, Knut. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:175:y:2022:i:c:s0040162521008519.

Full description at Econpapers || Download paper

2022Catalytic capacity of technological innovation: Multidimensional definition and measurement from the perspective of knowledge spillover. (2022). Zhang, Yang ; Hou, Jianhua ; Song, Haoyang. In: Technology in Society. RePEc:eee:teinso:v:68:y:2022:i:c:s0160791x22000392.

Full description at Econpapers || Download paper

2022Government intervention, spillover effect and urban innovation performance: Empirical evidence from national innovative city pilot policy in China. (2022). Yuan, Yijun ; Gao, Kang. In: Technology in Society. RePEc:eee:teinso:v:70:y:2022:i:c:s0160791x22001762.

Full description at Econpapers || Download paper

2022Language Barriers and the Speed of Knowledge Diffusion. (2022). Sadao, Nagaoka ; Higham, Kyle. In: Discussion papers. RePEc:eti:dpaper:22074.

Full description at Econpapers || Download paper

2021Impact of Aging and Underemployment on Income Disparity between Agricultural and Non-Agricultural Households. (2021). Chung, Chanjin ; Han, Joo Hun. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:21:p:11737-:d:663541.

Full description at Econpapers || Download paper

2021Highlighting the Drivers of Italian Diversified Farms Efficiency: A Two-Stage DEA-Panel Tobit Analysis. (2021). Forleo, Maria Bonaventura ; Giaccio, Vincenzo ; Romagnoli, Luca ; Mastronardi, Luigi. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:23:p:12949-:d:685668.

Full description at Econpapers || Download paper

2021Patent quality: Towards a Systematic Framework for Analysis and Measurement. (2021). Higham, Kyle ; de Rassenfosse, Gaétan ; Jaffe, Adam. In: Working Papers. RePEc:iip:wpaper:14.

Full description at Econpapers || Download paper

2021Rushed Innovation: Evidence from Drug Licensing. (2021). Hermosilla, Manuel. In: Management Science. RePEc:inm:ormnsc:v:67:y:2021:i:1:p:257-278.

Full description at Econpapers || Download paper

2022The influence of standards and patents on long-term economic growth. (2022). Rochell, Charlotte ; Ramel, Florian ; Blind, Knut. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:47:y:2022:i:4:d:10.1007_s10961-021-09864-3.

Full description at Econpapers || Download paper

2021Small firms and patenting revisited. (2021). fassio, claudio ; Athreye, Suma ; Roper, Stephen. In: Small Business Economics. RePEc:kap:sbusec:v:57:y:2021:i:1:d:10.1007_s11187-020-00323-1.

Full description at Econpapers || Download paper

2021Learning and dropout in contests: an experimental approach. (2021). Fallucchi, Francesco ; Riccaboni, Massimo ; Niederreiter, Jan. In: Theory and Decision. RePEc:kap:theord:v:90:y:2021:i:2:d:10.1007_s11238-020-09783-z.

Full description at Econpapers || Download paper

2022Trade Secret Protection and R&D Investment of Family Firms. (2022). Issah, Wunnam Basit ; Hussinger, Katrin. In: DEM Discussion Paper Series. RePEc:luc:wpaper:22-11.

Full description at Econpapers || Download paper

2021The translational lag narrative in policy discourse in the United States and the European Union: a comparative study. (2021). Blasimme, Alessandro ; Marelli, Luca ; Aarden, Erik. In: Palgrave Communications. RePEc:pal:palcom:v:8:y:2021:i:1:d:10.1057_s41599-021-00777-y.

Full description at Econpapers || Download paper

2021Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?. (2021). Versaevel, Bruno ; Scannell, Jack ; de Villemeur, Etienne Billette. In: MPRA Paper. RePEc:pra:mprapa:108233.

Full description at Econpapers || Download paper

2021Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis. (2021). Mahlich, Jörg ; Dheban, Srirangan ; Bartol, Arne. In: Health Economics Review. RePEc:spr:hecrev:v:11:y:2021:i:1:d:10.1186_s13561-021-00302-6.

Full description at Econpapers || Download paper

2021Borrower Learning Effects: Do Prior Experiences Promote Continuous Successes in Peer-to-Peer Lending?. (2021). Guo, Xun-Hua ; Shi, Yun ; Han, Jing-Ti ; Liu, Jian-Guo ; Chen, Qun. In: Information Systems Frontiers. RePEc:spr:infosf:v:23:y:2021:i:4:d:10.1007_s10796-020-10006-7.

Full description at Econpapers || Download paper

2021Patent Determinants for SMEs in Least-Developed Countries: How Enterprise Size Makes the Difference. (2021). AMDAOUD, Mounir ; Bas, Christian. In: Journal of the Knowledge Economy. RePEc:spr:jknowl:v:12:y:2021:i:2:d:10.1007_s13132-020-00650-4.

Full description at Econpapers || Download paper

2021The network origins of Schumpeterian innovation. (2021). Pammolli, Fabio ; Spelta, Alessandro ; Riccaboni, Massimo. In: Journal of Evolutionary Economics. RePEc:spr:joevec:v:31:y:2021:i:5:d:10.1007_s00191-021-00733-8.

Full description at Econpapers || Download paper

2022To what extent do SMEs contribute to Europe’s patent stock? A methodological outline for creating a Europe-wide SME technology indicator. (2022). Callaert, Julie ; Vervenne, Jan-Bart ; Looy, Bart ; Hoskens, Machteld . In: Scientometrics. RePEc:spr:scient:v:127:y:2022:i:6:d:10.1007_s11192-022-04360-3.

Full description at Econpapers || Download paper

2021Innovation crisis in the pharmaceutical industry? A survey. (2021). Backfisch, Martin ; Laermann-Nguyen, Ute. In: SN Business & Economics. RePEc:spr:snbeco:v:1:y:2021:i:12:d:10.1007_s43546-021-00163-5.

Full description at Econpapers || Download paper

2021Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model. (2021). Dosi, Giovanni ; Russo, Emanuele ; Roventini, Andrea ; Palagi, Elisa. In: LEM Papers Series. RePEc:ssa:lemwps:2021/37.

Full description at Econpapers || Download paper

2022The UK Gender Pay Gap: Does Firm Size Matter?. (2022). Kaya, Ezgi ; Jones, Melanie. In: GLO Discussion Paper Series. RePEc:zbw:glodps:1149.

Full description at Econpapers || Download paper

Works by Laura Magazzini:


YearTitleTypeCited
2019Does regulation drive international research cooperation? Evidence from the pharmaceutical sector In: The World Economy.
[Full Text][Citation analysis]
article0
In: .
[Full Text][Citation analysis]
paper0
2006Everything You Always Wanted to Know about Inventors (But Never Asked): Evidence from the PatVal-EU Survey In: CEPR Discussion Papers.
[Full Text][Citation analysis]
paper32
2005Everything you Always Wanted to Know about Inventors (but Never Asked): Evidence from the PatVal-EU Survey.(2005) In: LEM Papers Series.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 32
paper
2009A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development. In: KITeS Working Papers.
[Citation analysis]
paper39
2009A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development.(2009) In: Management Science.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 39
article
2007A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development.(2007) In: MPRA Paper.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 39
paper
2013Resale Price Maintenance: An Empirical Analysis of UK Firms Compliance In: Economic Journal.
[Full Text][Citation analysis]
article1
2020Exploiting information from singletons in panel data analysis: A GMM approach In: Economics Letters.
[Full Text][Citation analysis]
article1
2019Exploiting Information from Singletons in Panel Data Analysis: A GMM Approach.(2019) In: IZA Discussion Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 1
paper
2021R&D and market size: Who benefits from orphan drug legislation? In: Journal of Health Economics.
[Full Text][Citation analysis]
article1
2007Inventors and invention processes in Europe: Results from the PatVal-EU survey In: Research Policy.
[Full Text][Citation analysis]
article174
2003Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sullIndustria e Distorsioni nel Funzionamento del Mercato In: Working Papers CERM.
[Full Text][Citation analysis]
paper0
2005Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN In: Working Papers CERM.
[Full Text][Citation analysis]
paper0
2014Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dellItalia nel contesto europeo. In: Working Papers CERM.
[Full Text][Citation analysis]
paper0
2006La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica In: Working Papers CERM.
[Full Text][Citation analysis]
paper0
2007La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per lanalisi della variabilità regionale In: Working Papers CERM.
[Full Text][Citation analysis]
paper4
2009Nuove politiche per linnovazione nel settore delle scienze della vita In: Working Papers CERM.
[Full Text][Citation analysis]
paper0
2007Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico In: Working Papers CERM.
[Full Text][Citation analysis]
paper0
2005Medical Devices: Competitiveness and Impact on Public Health Expenditure In: Working Papers CERM.
[Full Text][Citation analysis]
paper17
2005Medical Devices Competitiveness and Impact on Public Health Expenditure.(2005) In: MPRA Paper.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 17
paper
2012The Value of Failures in Pharmaceutical R&D In: Working Papers.
[Full Text][Citation analysis]
paper4
2013R&D, Within and Between Patent Competition in the Pharmaceutical Industry In: Working Papers.
[Full Text][Citation analysis]
paper0
2004Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure In: MPRA Paper.
[Full Text][Citation analysis]
paper19
2008The Sustainability of European Health Care Systems: Beyond Income and Ageing In: MPRA Paper.
[Full Text][Citation analysis]
paper22
2012The sustainability of European health care systems: beyond income and aging.(2012) In: The European Journal of Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 22
article
2008The Sustainability of European Health Care Systems: Beyond Income and Ageing.(2008) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 22
paper
2001Simulation-based estimation of Tobit model with random effects In: MPRA Paper.
[Full Text][Citation analysis]
paper5
2002The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis In: Revue d'Économie Industrielle.
[Full Text][Citation analysis]
article9
2012Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood In: Empirical Economics.
[Full Text][Citation analysis]
article4
2009Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood.(2009) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 4
paper
2004Dynamic competition in pharmaceuticals In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article23
2016Learning from successes and failures in pharmaceutical R&D In: Journal of Evolutionary Economics.
[Full Text][Citation analysis]
article3
2009Patent disclosure and R&D competition in pharmaceuticals In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
article6
2009Patent Disclosure and R&D Competition in Pharmaceuticals..(2009) In: DISA Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 6
paper
2009Patent Disclosure and R&D Competition in Pharmaceuticals..(2009) In: ROCK Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 6
paper
2019Testing initial conditions in dynamic panel data models In: Econometric Reviews.
[Full Text][Citation analysis]
article1
2020Testing initial conditions in dynamic panel data models.(2020) In: Econometric Reviews.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 1
article
2020Using information from singletons in fixed-effects estimation: xtfesing In: Stata Journal.
[Full Text][Citation analysis]
article0
2021Maximum likelihood estimation of an across-regime correlation parameter In: Stata Journal.
[Full Text][Citation analysis]
article0
2011International Cooperation in Pharmaceutical Research In: Working Paper series, University of East Anglia, Centre for Competition Policy (CCP).
[Full Text][Citation analysis]
paper0
2009International Cooperation in Pharmaceutical Research.(2009) In: Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2011Moment Conditions and Neglected Endogeneity in Panel Data Models In: Working Papers.
[Full Text][Citation analysis]
paper0
2018The Joint Estimate of Singleton and Longitudinal Observations: a GMM Approach for Improved Efficiency In: Working Papers.
[Full Text][Citation analysis]
paper0
2010The productivity crisis in pharmaceutical R&D In: Working Papers.
[Full Text][Citation analysis]
paper42
2012Identification of linear panel data models when instruments are not available In: Working Papers.
[Full Text][Citation analysis]
paper0
2019R&D and market size: who benefits from orphan drug regulation? In: Working Papers.
[Full Text][Citation analysis]
paper1
2014Improving GMM efficiency in dynamic models for panel data with mean stationarity In: Working Papers.
[Full Text][Citation analysis]
paper1
2013A powerful test of mean stationarity in dynamic models for panel data: Monte Carlo evidence In: Working Papers.
[Full Text][Citation analysis]
paper2
2010Negative variance estimates in panel data models In: Working Papers.
[Full Text][Citation analysis]
paper2
2008Patent Value and R&D Competition In: Working Papers.
[Full Text][Citation analysis]
paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2023. Contact: CitEc Team